Lincoln International’s Global Healthcare Group Announces Record Year
Lincoln International remains one of the most active healthcare M&A advisors in 2021
Lincoln International’s global healthcare mergers and acquisitions (M&A) activity in 2021 eclipsed that of 2020 led by the firm’s growing sector capabilities and strong appetite for deals. In 2021, we completed transactions with or on behalf of some of the largest and most well-known names in healthcare private equity. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and healthcare information technology (IT) continues to strengthen. Lincoln is one of the only investment banks with dedicated, senior healthcare bankers covering markets across the Americas, Europe and Asia.
Summary
-
Lincoln International's global Healthcare Group celebrates record results in 2021.
Select Notable 2021 Healthcare Transactions
Related Perspectives
Meet Our Senior Team
It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew Lee
Managing Director, Head of UK & Co-head of Healthcare, Europe
LondonI enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director & Co-head of Healthcare, Europe
FrankfurtMy goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.
Roderick O’Neill
Managing Director & Co-head of Healthcare
New York